Literature DB >> 24939624

Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.

L M A Schreurs1, J K Smit, K Pavlov, B B Pultrum, J Pruim, H Groen, H Hollema, John Th M Plukker.   

Abstract

PURPOSE: To analyze the association between pretreatment 18-F-fluoro-deoxyglucose (FDG) uptake and characteristics of aggressive tumor biology in predicting outcome in esophageal cancer (EC).
METHODS: Tumor FDG-uptake was measured by maximum standardized uptake values (SUVmax) in 47 patients undergoing esophagectomy with curative intent. ROC analyses were used to predict an optimal SUVmax cutoff for survival. Expression of hexokinase-II (HK-II), glucose transporter I (GLUT-I), hypoxia inducible factor-1α (HIF-Iα), vascular endothelial growth factor-C (VEGF-C), p53, and proliferative activity (Ki-67) were correlated with SUVmax values and clinicopathological characteristics.
RESULTS: A SUVmax > 3.67 predicted a significantly lower disease-free survival (DFS) and distant recurrence-free survival (p = 0.022 and p = 0.005). High HK-II expression was correlated with reduced SUVmax values (p = 0.002) and was significantly higher in esophageal adenocarcinoma compared with squamous cell carcinoma (p = 0.005). Preoperative high FDG uptake in primary tumors was associated with nodal metastases (pN1; Spearman correlation 0.39, p = 0.01). We found no positive correlation between SUVmax and GLUT-1, HK-1, HIF-Iα 1, VEGF-C, p53, and Ki-67 expression.
CONCLUSIONS: High preoperative FDG-uptake strongly predicts poor survival outcome and is associated with lymph node metastases in EC patients. HK-II expression was related to SUVmax and DFS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24939624     DOI: 10.1245/s10434-014-3848-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

1.  Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.

Authors:  Varun Manoharan; Soon Lee; Shanley Chong; June Yap; Nick Coupe; Robert Wilson; Neil Merrett; Weng Ng; Michael Lin
Journal:  Ann Nucl Med       Date:  2017-03-15       Impact factor: 2.668

2.  One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer.

Authors:  Shuntaro Yoshimura; Miwako Takahashi; Susumu Aikou; Yasuhiro Okumura; Keiichi Jinbo; Haruna Onoyama; Masayuki Urabe; Koichiro Kawasaki; Koichi Yagi; Masato Nishida; Kazuhiko Mori; Hiroharu Yamashita; Sachiyo Nomura; Keitaro Koyama; Toshimitsu Momose; Hiroyuki Abe; Tetsuo Ushiku; Masashi Fukayama; Yasuyuki Seto
Journal:  Clin Nucl Med       Date:  2020-10       Impact factor: 10.782

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.